Travis Doupe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing...

Willow" or the " Company") (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the " Common Shares") of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 million (the " Offering"). Participation in the Offering was comprised primarily of existing cornerstone shareholders and new institutional buyside funds. Net procee...

19 febbraio 2021 17:28 Fonte: Adnkronos #chimica-e-farmacia VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ -- Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the "Common Shares") of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 million (the "Offering"). Particip...